Recent Lab News:
October 1, 2020
Dr. Roalf’s lab receives grant from NIMH to study changes in brain glutamate in healthy older and young adults.
June 1, 2020
Dr. Roalf’s lab receives grant from NIMH to study changes in brain glutamate in youth at risk for psychosis.
October 1, 2019
Dr. Roalf’s lab receives grant from NIMH to study olfactory and facial markers of developmental risk for psychosis in 22q11 deletion syndrome.
December 22, 2016
Our work featured on NPR’s NewsWorks Tonight (WHYY)
Scientists at the University of Pennsylvania have found that a smell test can help detect early signs of Alzheimer’s Disease
December 21, 2016
Journal of Alzheimer’s Disease Press Release
December 20, 2016
Penn Study Confirms That “Sniff Test” May Be Useful in Diagnosing Early Alzheimer’s Disease
September 1, 2016
Dr. Roalf receives NARSAD Young Investigator Award from the Brain & Behavior Research Foundation to study changes in brain glutamate and glutathione in young adults with psychosis.
May 4, 2016
Early detection of cognitive impairment is becoming an important clinical and public health concern,” explained Penn Medicine’s David R. Roalf, PhD, a research assistant professor in Psychiatry and Institute on Aging (IOA) Fellow.
April 16, 2016
“Dr Roalf and his colleagues developed a short form of the MoCA by employing item response theory and computerized adaptive testing simulation in 1850 participants with and without neurodegenerative disease.” –Neurology Advisor